Edwards Lifesciences Corp — Director's Dealing 2011

Aug 30, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2011-08-26

Reporting Person: Verguet Patrick B (CVP, Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-26	Common Stock	M	12000.0000	$22.9500	Acquired	60382.0000	Direct
2011-08-26	Common Stock	S	12000.0000	$72.1800	Disposed	48382.0000	Direct
2011-08-29	Common Stock	M	5000.0000	$22.9500	Acquired	53382.0000	Direct
2011-08-29	Common Stock	S	5000.0000	$74.5300	Disposed	48382.0000	Direct
2011-08-30	Common Stock	M	5000.0000	$22.9500	Acquired	53382.0000	Direct
2011-08-30	Common Stock	M	5000.0000	$74.5000	Disposed	48382.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-26	Employee Stock Option (Right to Acquire)	$22.9500	M	12000.0000	Disposed	2012-05-11	Common Stock (12000.0000)	Direct
2011-08-29	Employee Stock Option (Right to Acquire)	$22.9500	M	5000.0000	Disposed	2012-05-11	Common Stock (5000.0000)	Direct
2011-08-30	Employee Stock Option (Right to Acquire)	$22.9500	M	5000.0000	Disposed	2012-05-11	Common Stock (5000.0000)	Direct

Footnotes

F1: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.

F2: This transaction was executed in multiple trades at prices ranging from $72.07 to $72.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $74.50 to $74.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.